by CU Anschutz Medical Campus Credit: Pixabay/CC0 Public Domain Researchers have conducted one of the first studies to examine the effectiveness of nirmatrelvir-ritonavir (Paxlovid) in non-hospitalized patients during an omicron period of the COVID-19 pandemic that includes BA.4 and BA.5 subvariants. Though many Coloradans are proceeding as though the COVID-19 pandemic is over, the virus continues to circulate,...
GOETHE UNIVERSITY FRANKFURT FRANKFURT. The Omicron variant of the SARS-CoV-2 virus was first detected in South Africa in November 2021. The high level of infectiousness of the virus and its ability to quickly spawn additional variants has also been observed in Germany: Since January 2022 the Omicron variant BA.1 has dominated here, followed in subsequent...
by Bill Hathaway, Yale University Credit: Pixabay/CC0 Public Domain Yale scientists have developed a novel omicron-specific mRNA vaccine that offers superior immune protection against two viral subvariants than standard mRNA vaccines. The new vaccine, called Omnivax, increased neutralizing antibody response against the BA.1 and BA.2.12.1 omicron subvariants in pre-immunized mice 19-fold and eight-fold, respectively, compared...
by Regenstrief Institute Credit: Pixabay/CC0 Public Domain In one of the first investigations of the effectiveness of a second mRNA booster against COVID-19 Omicron variants, a study from the U.S. Centers for Disease Control and Prevention (CDC) has found that a second booster shot significantly improved effectiveness against widespread variants Omicron BA.1 and BA.2/BA.2.12.1. With...
By Rich Haridy June 29, 2022 New data, yet to be peer-reviewed and published in a journal, indicates Novavax’s vaccine induces a strong antibody response against all circulating Omicron variants Depositphotos Biotech company Novavax has revealed its COVID-19 vaccine can generate effective immune responses against all circulating Omicron variants. The unexpected data was delivered to...
by Emily Caldwell, The Ohio State University A COVID-19 booster shot will provide strong and broad antibody protection against the range of omicron sublineage variants of the SARS-CoV-2 virus in circulation, two new studies using serum from human blood samples suggest. Researchers tested neutralizing antibody levelsagainst the BA.2 and BA.3 omicron variants and deltacron, a recombinant variant created...
